Notice of Proposed Sale · 144
Outset Medical, Inc.
OMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Outset Medical, Inc.
- Issuer CIK
- 0001484612
- SEC file number
- 001-39513
- Phone
- 669-231-8200
- Person for whose account securities are to be sold
- Gaeta Renee
- Relationships to issuer
- Officer
- Street
- 3052 ORCHARD DRIVE
- City
- SAN JOSE
- State / country code
- CA
- Postal code
- 95134
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 4,422 | 19,939.32 | 18,800,114 | 08/17/2026 | NASDAQ | Morgan Stanley Smith Barney LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC
- Street
- 1 New York Plaza
- Street (continued)
- 38th Fl
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 08/15/2026 | Settlement of Vested Restricted Stock Units | Issuer | 12,322 | N | 08/17/2026 | Equity Compensation for services rendered |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Renee Gaeta | Common Stock | 06/03/2026 | 17,672 | 87,384.92 |
Seller — prior-sale row 1, entry 1
- Name
- Renee Gaeta
- Street
- 3052 Orchard Dr
- City
- San Jose
- State / country code
- CA
- Postal code
- 95134
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
This sale was made to satisfy tax withholding obligations through a sell to cover transaction in connection with the vesting of Restricted Stock Units and does not represent a discretionary trade by the reporting person.
Notice signature
- Notice date
- 08/14/2026
- Signed
- /s/ John L Brottem POA
Company context
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control - enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.